Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 380,147 |
|
|||||
| News | - | ||||||
| Day High | 0.355 | Low High |
|||||
| Day Low | 0.33 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Clene Inc | CLNN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0064 | -1.90% | 0.3306 | 18:56:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.335 | 0.33 | 0.355 | 0.3465 | 0.337 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 816 | 380,147 | $ 0.3441279 | $ 130,819 | - | 0.25 - 1.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:36:13 | 2 | $ 0.3465 | USD |
Clene Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 44.95M | 128.43M | - | 654k | -49.5M | -0.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Clene News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLNN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3253 | 0.359 | 0.307 | 0.3377256 | 749,939 | 0.0053 | 1.63% |
| 1 Month | 0.43 | 0.46 | 0.304 | 0.3391457 | 1,470,700 | -0.0994 | -23.12% |
| 3 Months | 0.49 | 0.5323 | 0.304 | 0.3856368 | 955,706 | -0.1594 | -32.53% |
| 6 Months | 0.4562 | 0.60 | 0.25 | 0.3796785 | 911,736 | -0.1256 | -27.53% |
| 1 Year | 0.99 | 1.09 | 0.25 | 0.499763 | 677,286 | -0.6594 | -66.61% |
| 3 Years | 9.925 | 17.82 | 0.25 | 2.54 | 543,608 | -9.59 | -96.67% |
| 5 Years | 9.87 | 17.82 | 0.25 | 2.95 | 513,017 | -9.54 | -96.65% |
Clene Description
| Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). |
